| URN | urn:agi-llid:5467 |
|---|---|
| Name | PPARD |
| Description | peroxisome proliferator-activated receptor delta |
| Connectivity | 483 |
| Notes | This gene encodes a member of the peroxisome proliferator-activated receptor (PPAR) family. PPARs are nuclear hormone receptors that bind peroxisome proliferators and control the size and number of peroxisomes produced by cells. PPARs mediate a variety of biological processes, and may be involved in the development of several chronic diseases, including diabetes, obesity, atherosclerosis, and cancer. This protein is a potent inhibitor of ligand-induced transcription activity of PPAR alpha and PPAR gamma. It may function as an integrator of transcription repression and nuclear receptor signaling. The expression of this gene is found to be elevated in colorectal cancer cells. The elevated expression can be repressed by adenomatosis polyposis coli (APC), a tumor suppressor protein related to APC/beta-catenin signaling pathway. Knockout studies in mice suggested the role of this protein in myelination of the corpus callosum, lipid metabolism, and epidermal cell proliferation. |
| Swiss-Prot Accession | Q03181 |
|---|---|
| Q5D1P0 | |
| P35396 | |
| Q546I3 | |
| Q7TSY1 | |
| Q62879 | |
| Q99ND3 | |
| Q9QWI0 |
| Unigene ID | Hs.696032 |
|---|---|
| Mm.328914 | |
| Rn.96181 |
| KEGG ID | hsa:5467 |
|---|---|
| rno:25682 | |
| mmu:19015 |
| Swiss-Prot ID | PPARD_HUMAN |
|---|---|
| PPARD_MOUSE | |
| Q5D1P0_HUMAN | |
| Q546I3_MOUSE | |
| Q62879_RAT |
| Cell Localization | Nucleus |
|---|
| GO ID | 0051059 |
|---|---|
| 0008144 | |
| 0005504 | |
| 0046872 | |
| 0043565 | |
| 0003707 | |
| 0003700 | |
| 0016564 | |
| 0008270 | |
| 0042640 | |
| 0006915 | |
| 0008366 | |
| 0030154 | |
| 0031589 | |
| 0008203 | |
| 0046697 | |
| 0007566 | |
| 0008544 | |
| 0006635 | |
| 0015908 | |
| 0006091 | |
| 0006006 | |
| 0015758 | |
| 0051546 | |
| 0043616 | |
| 0006629 | |
| 0000122 | |
| 0045600 | |
| 0014068 | |
| 0006350 | |
| 0006776 | |
| 0042060 | |
| 0005634 | |
| 0003677 | |
| 0008047 | |
| 0004879 | |
| 0016501 | |
| 0005515 | |
| 0046982 | |
| 0004872 | |
| 0046965 | |
| 0008283 | |
| 0009987 | |
| 0050680 | |
| 0001890 | |
| 0008284 | |
| 0042127 | |
| 0045598 | |
| 0050796 | |
| 0006355 | |
| 0019395 | |
| 0043124 | |
| 0048265 | |
| 0009266 |
| Pathway | NIH Omega 3 |
|---|---|
| BCL6 | |
| HepG2 Extracts | |
| MR 05/06/09 14:12:19 | |
| MR 05/06/09 14:18:08 | |
| Cardiovascular Disease (Large) | |
| CVD Transcription factors | |
| 'CVD Transcription factors' + Ligands | |
| CVD and receptors | |
| CVD and receptors (all) | |
| CVD and receptors (all) + Ligands | |
| Figure 3 CAR 2009 | |
| PPARbeta BCL6 Targets | |
| PPARG Targets | |
| PPARbeta Targets | |
| VDR Targets |
| IPI ID | IPI00009330 |
|---|---|
| IPI00219761 | |
| IPI00271799 | |
| IPI00325169 |
| Ariadne Ontology | Thr-like |
|---|
| Mouse chromosome position | 17 13.5 cM |
|---|
| GO Molecular Function | protein binding |
|---|---|
| drug binding | |
| metal ion binding | |
| zinc ion binding | |
| fatty acid binding | |
| DNA binding | |
| sequence-specific DNA binding | |
| transcription factor activity | |
| protein heterodimerization activity | |
| retinoid X receptor binding | |
| NF-kappaB binding | |
| enzyme activator activity | |
| receptor activity | |
| ligand-dependent nuclear receptor activity | |
| steroid hormone receptor activity | |
| prostacyclin receptor activity | |
| transcription repressor activity |
| Homologene ID | 4544 |
|---|
| Hugo ID | 9235 |
|---|
| GO Cellular Component | nucleus |
|---|
| MGI ID | 101884 |
|---|
| Human chromosome position | 6p21.2-p21.1 |
|---|
| GO Biological Process | cellular process |
|---|---|
| cell-substrate adhesion | |
| negative regulation of I-kappaB kinase-NF-kappaB cascade | |
| negative regulation of epithelial cell proliferation | |
| negative regulation of transcription from RNA polymerase II promoter | |
| positive regulation of cell proliferation | |
| positive regulation of phosphoinositide 3-kinase cascade | |
| positive regulation of fat cell differentiation | |
| regulation of cell proliferation | |
| regulation of insulin secretion | |
| regulation of fat cell differentiation | |
| regulation of transcription, DNA-dependent | |
| axon ensheathment | |
| cell proliferation | |
| apoptosis | |
| keratinocyte migration | |
| keratinocyte proliferation | |
| cell differentiation | |
| generation of precursor metabolites and energy | |
| glucose metabolic process | |
| cholesterol metabolic process | |
| transcription | |
| fatty acid beta-oxidation | |
| fatty acid oxidation | |
| vitamin A metabolic process | |
| embryo implantation | |
| placenta development | |
| decidualization | |
| epidermis development | |
| anagen | |
| glucose transport | |
| fatty acid transport | |
| lipid metabolic process | |
| response to pain | |
| response to temperature stimulus | |
| wound healing |
| Rat chromosome position | 20p12 |
|---|
| Group | Thr-like |
|---|---|
| nucleus | |
| protein binding | |
| drug binding | |
| metal ion binding | |
| zinc ion binding | |
| fatty acid binding | |
| DNA binding | |
| sequence-specific DNA binding | |
| transcription factor activity | |
| protein heterodimerization activity | |
| retinoid X receptor binding | |
| NF-kappaB binding | |
| enzyme activator activity | |
| receptor activity | |
| ligand-dependent nuclear receptor activity | |
| steroid hormone receptor activity | |
| prostacyclin receptor activity | |
| transcription repressor activity | |
| cellular process | |
| cell-substrate adhesion | |
| negative regulation of I-kappaB kinase-NF-kappaB cascade | |
| negative regulation of epithelial cell proliferation | |
| negative regulation of transcription from RNA polymerase II promoter | |
| positive regulation of cell proliferation | |
| positive regulation of phosphoinositide 3-kinase cascade | |
| positive regulation of fat cell differentiation | |
| regulation of cell proliferation | |
| regulation of insulin secretion | |
| regulation of fat cell differentiation | |
| regulation of transcription, DNA-dependent | |
| axon ensheathment | |
| cell proliferation | |
| apoptosis | |
| keratinocyte migration | |
| keratinocyte proliferation | |
| cell differentiation | |
| generation of precursor metabolites and energy | |
| glucose metabolic process | |
| cholesterol metabolic process | |
| transcription | |
| fatty acid beta-oxidation | |
| fatty acid oxidation | |
| vitamin A metabolic process | |
| embryo implantation | |
| placenta development | |
| decidualization | |
| epidermis development | |
| anagen | |
| glucose transport | |
| fatty acid transport | |
| lipid metabolic process | |
| response to pain | |
| response to temperature stimulus | |
| wound healing |
| MedScan ID | 5467 |
|---|
| RGD ID | 3370 |
|---|
| LocusLink ID | 5467 |
|---|---|
| 19015 | |
| 25682 |
| Alias | FAAR |
|---|---|
| NUC1 | |
| NUCI | |
| NR1C2 | |
| NUCII | |
| PPARB | |
| MGC3931 | |
| PPAR-beta | |
| peroxisome proliferative activated receptor, delta | |
| OTTHUMP00000016256 | |
| nuclear hormone receptor 1 | |
| NUC-1 | |
| PPAR[b] | |
| Pparb/d | |
| PPARdelta | |
| PPAR-delta | |
| peroxisome proliferator activator receptor delta | |
| mPPAR(delta) | |
| PPARdelta/beta | |
| OTTMUSP00000027308 | |
| Peroxisome proliferator-activated receptor beta | |
| peroxisome proliferator-activated receptor delta | |
| peroxisome proliferator activator receptor beta | |
| peroxisome proliferator activated receptor delta | |
| peroxisome proliferator activator receptor, delta | |
| PPAR(b) | |
| Ppard | |
| Peroxisome proliferator activated receptor beta | |
| PPAR- delta | |
| Nuclear hormone receptor I | |
| NUC I | |
| Pparb/ds | |
| PPAR[b]s | |
| mppar | |
| peroxisome proliferator activator receptor |
| Organism | Homo sapiens |
|---|---|
| Mus musculus | |
| Rattus norvegicus |
| OMIM ID | 600409 |
|---|